KSR2 Antibody

Basic Research Questions

• What is KSR2 and why is it important in scientific research?

  KSR2 (Kinase Suppressor of Ras 2) is an intracellular scaffolding protein involved in multiple signaling pathways, particularly the Raf-MEK-ERK pathway. It plays a crucial role in energy homeostasis, substrate utilization, and metabolic regulation. The importance of KSR2 in research has grown significantly since the discovery that targeted deletion of Ksr2 leads to obesity in mice, suggesting its fundamental role in metabolism. In humans, rare variants in KSR2 have been identified in individuals with severe early-onset obesity, linking it to hyperphagia, reduced basal metabolic rate, and insulin resistance. Additionally, recent research has revealed KSR2's unexpected role in small-cell lung carcinoma (SCLC), particularly in promoting self-renewal and clonogenicity of tumor cells. Understanding KSR2 function offers potential therapeutic targets for both metabolic disorders and certain cancers .

• How do I select the appropriate KSR2 antibody for my research application?

  Selection of an appropriate KSR2 antibody requires careful consideration of several factors. First, determine your experimental application (western blotting, immunoprecipitation, immunohistochemistry, flow cytometry, etc.) as antibodies perform differently across these techniques. Consider the protein isoform you're targeting—research has identified at least two KSR2 isoforms (KSR2_950 and KSR2_921) that differ in their first 29 amino acids and have varying functional properties. The KSR2_950 isoform is expressed at higher levels and demonstrates superior binding to B-Raf and facilitation of MEK and ERK phosphorylation compared to KSR2_921 .

  For antibody selection, evaluate specificity through validation data including positive and negative controls. Consider species reactivity—if you're studying both mouse and human samples, select antibodies with cross-reactivity or obtain species-specific antibodies. If studying specific phosphorylation events or protein interactions, consider phospho-specific or domain-specific antibodies. Finally, review literature citing specific antibodies in applications similar to yours for validation of performance in comparable experimental contexts.

• What are the best methods for validating KSR2 antibody specificity?

  Validating KSR2 antibody specificity requires multiple complementary approaches. Primary validation should include western blot analysis comparing wildtype samples with KSR2 knockout or knockdown controls. Research protocols demonstrate effective KSR2 knockdown using SMARTvector inducible lentiviral shRNAs or CRISPR/Cas9 targeting of KSR2 with appropriate sgRNAs . These genetic controls provide critical negative controls to confirm antibody specificity.

  Additional validation approaches include:

  • Peptide competition assays to demonstrate binding specificity

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

  • Comparing detection patterns across multiple KSR2 antibodies targeting different epitopes

  • Tissue/cell expression pattern correlation with known KSR2 expression profiles

  • Testing for cross-reactivity with related proteins, particularly KSR1

  For quantitative applications, establish a standard curve using recombinant KSR2 protein to determine detection limits and linear range. Document all validation procedures thoroughly, including positive and negative controls, to ensure experimental reproducibility and reliable interpretation of results.

• What sample preparation techniques optimize KSR2 detection in different experimental contexts?

  Optimal sample preparation for KSR2 detection varies by experimental application. For protein extraction and western blotting, radioimmunoprecipitation assay (RIPA) buffer containing 50 mM Tris-HCl, 1% NP-40, 0.5% Na deoxycholate, 0.1% Na dodecyl sulfate, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, and protease and phosphatase inhibitors (aprotinin 0.5 U/mL, leupeptin 20 mM, and NA3VO4 0.5 mM) effectively preserves KSR2 and its phosphorylation state .

  For immunoprecipitation studies, gentler lysis buffers containing 0.5-1% NP-40 may better preserve protein-protein interactions of KSR2 with binding partners like AMPK or components of the Raf-MEK-ERK pathway. When performing immunohistochemistry, optimal fixation methods include 4% paraformaldehyde for 24-48 hours followed by paraffin embedding, with antigen retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0).

  For flow cytometry applications, particularly when examining KSR2 in tumor propagating cells (TPCs), fresh cell preparation with minimal processing time is crucial. In all applications, including appropriate controls (positive, negative, isotype) is essential for result interpretation and troubleshooting.

• How do KSR2 expression patterns differ across tissue types and disease states?

  KSR2 exhibits distinct expression patterns across tissues and disease states, requiring careful consideration when designing antibody-based detection studies. In normal physiology, KSR2 is expressed in pulmonary neuroendocrine cells and plays roles in metabolic regulation through interaction with AMPK . The detection of KSR2 in these contexts requires appropriately sensitive and specific antibodies.

  In pathological conditions, KSR2 demonstrates altered expression patterns. Recent research reveals previously unrecognized KSR2 expression in small-cell lung carcinoma (SCLC), preferentially in the ASCL1 subtype (SCLC-A) . This finding represents a novel model for understanding KSR2-dependent signaling in both normal and malignant tissues.

  In metabolic disorders, rare variants in KSR2 have been identified in individuals with severe early-onset obesity. These variants disrupt signaling through the Raf-MEK-ERK pathway and impair cellular fatty acid oxidation and glucose oxidation . When designing studies to detect KSR2 variants, researchers should consider whether their antibodies recognize epitopes that might be affected by these variants or post-translational modifications.

  The expression differences highlight the importance of proper controls when using KSR2 antibodies, including tissue-specific positive controls and disease-state samples with known KSR2 expression profiles.

Common KSR2 Detection Methods and Applications